Adar Poonawalla, Serum Institute of India CEO (Dhiraj Singh/Bloomberg via Getty Images)
GreenLight licenses mRNA shingles vaccine to Serum Institute following a $10M investment
GreenLight Biosciences has come a long way from trying to shake up the pesticides market.
The Medford, MA biotech signed a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
